These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 34297710)

  • 41. Observational research on severe COVID-19 in diabetes.
    Stehouwer CDA
    Lancet Diabetes Endocrinol; 2021 Feb; 9(2):56-57. PubMed ID: 33357490
    [No Abstract]   [Full Text] [Related]  

  • 42. Personal Experience With COVID-19 and Community Screening of Diabetic Retinopathy in Iran.
    Jamali S; Ashrafi E; Mohammadi SF
    J Diabetes Sci Technol; 2020 Jul; 14(4):737-738. PubMed ID: 32460540
    [No Abstract]   [Full Text] [Related]  

  • 43. Microvascular disease in diabetes and severe COVID-19 outcomes.
    Corcillo A; Whyte MB; Vas P; Karalliedde J
    Lancet Diabetes Endocrinol; 2021 Apr; 9(4):200-201. PubMed ID: 33740436
    [No Abstract]   [Full Text] [Related]  

  • 44. Diabetic emergencies during the COVID-19 pandemic: A case-control study.
    Huda MSB; Shaho S; Trivedi B; Fraterrigo G; Chandrarajan L; Zolfaghari P; Dovey TM; Garrett CG; Chowdhury TA
    Diabet Med; 2021 Jan; 38(1):e14416. PubMed ID: 33025636
    [No Abstract]   [Full Text] [Related]  

  • 45. The effect of COVID-19 on routine diabetes care and mortality in people with diabetes.
    Hopkins D; Rubino F
    Lancet Diabetes Endocrinol; 2022 Aug; 10(8):550-551. PubMed ID: 35636442
    [No Abstract]   [Full Text] [Related]  

  • 46. International Diabetes Center: COVID-19 Won't Stop Us From Fulfilling Our Mission.
    Davidson JL; Johnson ML; Simonson GD; Criego AB; Martens TW; Carlson AL; Bergenstal RM
    J Diabetes Sci Technol; 2020 Jul; 14(4):725-726. PubMed ID: 32408824
    [No Abstract]   [Full Text] [Related]  

  • 47. Telemedicine for Diabetes After the COVID-19 Pandemic: We Can't Put the Toothpaste Back in the Tube or Turn Back the Clock.
    Klonoff DC
    J Diabetes Sci Technol; 2020 Jul; 14(4):741-742. PubMed ID: 32506942
    [No Abstract]   [Full Text] [Related]  

  • 48. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.
    Buetti N; Trimboli P; Mazzuchelli T; Lo Priore E; Balmelli C; Trkola A; Conti M; Martinetti G; Elzi L; Ceschi A; Consonni V; Ogna A; Forni-Ogna V; Bernasconi E
    Endocrine; 2020 Dec; 70(3):454-460. PubMed ID: 32870469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microvascular disease in diabetes and severe COVID-19 outcomes - Authors' reply.
    Colhoun HM; McGurnaghan SJ; McKeigue PM
    Lancet Diabetes Endocrinol; 2021 Apr; 9(4):201. PubMed ID: 33740437
    [No Abstract]   [Full Text] [Related]  

  • 50. Preexisting prediabetes and the severity of COVID-19.
    Sathish T; Cao Y; Kapoor N
    Prim Care Diabetes; 2021 Feb; 15(1):28-29. PubMed ID: 32958435
    [No Abstract]   [Full Text] [Related]  

  • 51. Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily.
    Silverii GA; Monami M; Cernigliaro A; Vigneri E; Guarnotta V; Scondotto S; Allotta VA; Conti M; Giordano C; Mannucci E
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):396-398. PubMed ID: 33223405
    [TBL] [Abstract][Full Text] [Related]  

  • 52. COVID-19 pandemic, coronaviruses, and diabetes mellitus.
    Muniyappa R; Gubbi S
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E736-E741. PubMed ID: 32228322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diabetes Management during the COVID-19 Pandemic: An Iranian Expert Opinion Statement.
    Malek M; Hosseinpanah F; Aghaei Meybodi HR; Jahed SA; Hadaegh F; Sharghi S; Esteghamati A; Khamseh ME
    Arch Iran Med; 2020 Aug; 23(8):564-567. PubMed ID: 32894970
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Challenges of diabetes care management in developing countries with a high incidence of COVID-19: A brief report.
    Nouhjah S; Jahanfar S
    Diabetes Metab Syndr; 2020; 14(5):731-732. PubMed ID: 32473905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity.
    Klonoff DC; Umpierrez GE
    Metabolism; 2020 Jul; 108():154224. PubMed ID: 32275971
    [No Abstract]   [Full Text] [Related]  

  • 56. Pre-existing diabetes is worse for SARS-CoV-2 infection; an endothelial perspective.
    La Sala L; Luzi L; Pontiroli AE
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1855-1856. PubMed ID: 32807635
    [No Abstract]   [Full Text] [Related]  

  • 57. The Impact of COVID-19 on Diabetes Research in Canada.
    Dyck JRB
    Can J Diabetes; 2020 Jul; 44(5):369. PubMed ID: 32405267
    [No Abstract]   [Full Text] [Related]  

  • 58. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China.
    Zhou J; Tan J
    Metabolism; 2020 Jun; 107():154216. PubMed ID: 32220612
    [No Abstract]   [Full Text] [Related]  

  • 59. Covid-19 and Diabetes Mellitus.
    Attri B; Gupta Y; Tandon N
    Natl Med J India; 2021; 34(3):129-131. PubMed ID: 34825533
    [No Abstract]   [Full Text] [Related]  

  • 60. COVID-19 Pandemic Triggers Telemedicine Regulation and Intensifies Diabetes Management Technology Adoption in Brazil.
    Teles M; Sacchetta T; Matsumoto Y
    J Diabetes Sci Technol; 2020 Jul; 14(4):797-798. PubMed ID: 32482098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.